Skip to main content

Table 2 Assay performance

From: The effect of intravenous interleukin-1 receptor antagonist on inflammatory mediators in cerebrospinal fluid after subarachnoid haemorrhage: a phase II randomised controlled trial

Analyte

Plasma

CSF

 

Sensitivity (pg/mL)

Inter-assay CV range (QC concentration range)

Sensitivity (pg/mL)

Inter-assay CV range (QC concentration range)

IL-1Ra

16

8.2 to 3.2 (360 to 10,009 pg/mL)

Same assay as for plasma

IL-1α

6.1

9.0 to 4.2 (25 to 366 pg/mL)

4.75

6.6 to 9.2 (20 to 800 pg/mL)

IL-1β

1.3

10.3 to 6.3 (17.5 to 146 pg/mL)

0.48

30.3 to 10.9 (1.3 to 10.9 pg/mL)

IL-6

1.7

5.9 to 2 (41 to 322 pg/mL)

17

7.1 to 2.6 (213 to 1,229 pg/mL)

IL-8

4.7

7.9 to 16 (109 to 975 pg/mL)

17

8.9 to 15.8 (185 to 9,152 pg/mL)

IL-10

1.3

10.3 to 6.26 (7.5 to 146 pg/mL)

0.82

10.6 to 5.5 (5.16 to 232 pg/mL)

MCP-1

45

19.5 to 11.3 (207 to 1,759 pg/mL)

147

(19 to 6.5 (9,303 to 11,275 pg/mL)

TNF-α

0.35

6.7 to 7.0 (16.8 to 159 pg/mL)

2.5

25 to 15.8 (4.3 to 28.1 pg/mL)

CRP

350

14.8 to 1 (9.2 to 97 mg/L)

ND

  1. The assay performance data is only for assays used in this study. The lowest sensitivity of the assays is shown and represents either the non-sample value (+2 SD), or the lowest point on the standard curve. Inter-assay CVs are shown from the lowest to the highest concentration of QCs (three or four) that were included in all assays. CRP, C-reactive protein; CV, coefficient of variation; IL, interleukin; IL-1Ra, interleukin-1 receptor antagonist; MCP-1, monocyte chemoattractant protein-1; ND, not determined; QC, quality control; TNF, tumour necrosis factor.